Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States

Hereditary angioedema (HAE) is a rare genetic disorder with substantial morbidity and mortality. Despite expanded choices for effective acute treatment, prophylactic options are more limited. Intravenous C1 esterase inhibitor (C1-INH[IV]) is licensed and used to prevent HAE symptoms.

http://ift.tt/2t05b7m